Pediatrics Doctors in Semmes, AL Accepting Medicare
1 Pediatrics doctors found. Showing 1 - 1
 Dr. Rhonda R Bedsole, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 3810 Wulff Rd E, Semmes, AL 36575 Phone: 251-445-0582 Fax: 251-445-0584 |
News Archive
ASTRO announces launch of Advances in Radiation Oncology journal
The American Society for Radiation Oncology is pleased to announce the launch of its new open-access journal, Advances in Radiation Oncology, and the selection of its Founding Editor, Robert C. Miller, MD, MBA. Advances will begin accepting manuscripts by the end of the summer with studies to be published by late 2015.
Many details still bedevil Democrats in health reform bills
It was the usual partisan squabbling on the Sunday talk shows today, while Democrats are braced for a significant week ahead, ironing out significant differences in various health reform bills.
APCER comments on FDA's decision regarding electronic submission of reports
APCER Pharma Solutions, Inc. ("APCER") President and CEO Suneet Walia commented on the US Food and Drug Administration's (FDA) proposed rules to amend postmarket safety reporting regulations for three of its centers, to require manufacturers and other facilities subject to current reporting requirements to submit their reports electronically.
U.S. needs national HIV/AIDS plan, should focus resources on epidemic's trends, opinion piece says
The recent CDC report on new HIV infections "underscore[s] ... the inexorable movement of the HIV/AIDS epidemic into black and other minority communities and the failure of government at all levels to respond to that change," C. Virginia Fields, president and CEO of the National Black Leadership Commission on AIDS, writes in a New York Daily News opinion piece (Fields, New York Daily News, 8/31).
Ampio completes partial planned interim review in Optina trial for diabetic macular edema
Ampio Pharmaceuticals, Inc., a biopharmaceutical company conducting clinical trials on its three lead drugs (Zertane completed two phase III studies, Ampion-completed proof of concept studies and Optina), licensing distribution of these drugs and engaged in further drug development, today announced that it completed the planned interim review of the first 50% of patients enrolled in the Optina trial for diabetic macular edema.
› Verified 1 days ago